KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Depreciation & Amortization - TotalEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Non-Controlling InterestsInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

National Health Investors (NHI) Other Operating Expenses (2016 - 2026)

National Health Investors filings provide 18 years of Other Operating Expenses readings, the most recent being $70.2 million for Q1 2026.

  • On a quarterly basis, Other Operating Expenses rose 133.74% to $70.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $193.0 million, a 542.71% increase, with the full-year FY2023 number at $20000.0, up 102.86% from a year prior.
  • Other Operating Expenses hit $70.2 million in Q1 2026 for National Health Investors, up from $62.2 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $70.2 million in Q1 2026 to a low of -$729000.0 in Q2 2022.
  • Median Other Operating Expenses over the past 5 years was $28.8 million (2024), compared with a mean of $26.4 million.
  • Biggest five-year swings in Other Operating Expenses: soared 157.88% in 2022 and later plummeted 33.9% in 2023.
  • National Health Investors' Other Operating Expenses stood at $10000.0 in 2022, then skyrocketed by 100.0% to $20000.0 in 2023, then soared by 139775.0% to $28.0 million in 2024, then skyrocketed by 122.3% to $62.2 million in 2025, then grew by 12.84% to $70.2 million in 2026.
  • The last three reported values for Other Operating Expenses were $70.2 million (Q1 2026), $62.2 million (Q4 2025), and $31.0 million (Q3 2025) per Business Quant data.